Page last updated: 2024-09-05

cgp 54626 and 6-cyano-7-nitroquinoxaline-2,3-dione

cgp 54626 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies

Compound Research Comparison

Studies
(cgp 54626)
Trials
(cgp 54626)
Recent Studies (post-2010)
(cgp 54626)
Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)
Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)
Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
570162,6981353

Protein Interaction Comparison

ProteinTaxonomycgp 54626 (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortez, MA; Eubanks, JH; Han, H; Leschenko, Y; Perez Velazquez, JL; Snead, OC; Stewart, LS; Wu, Y1
Crunelli, V; David, F; Lambert, RC; Leresche, N1

Other Studies

2 other study(ies) available for cgp 54626 and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific.
    Epilepsy & behavior : E&B, 2009, Volume: 14, Issue:4

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Autoradiography; Cognition Disorders; Disease Models, Animal; Electric Stimulation; Electroencephalography; Epilepsy, Absence; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Long-Term Potentiation; Maze Learning; Mice; Mice, Transgenic; Neurons; Organophosphorus Compounds; Patch-Clamp Techniques; Phenotype; Protein Binding; Receptors, GABA-B; Tritium; Valine

2009
Dynamic Analysis of the Conditional Oscillator Underlying Slow Waves in Thalamocortical Neurons.
    Frontiers in neural circuits, 2016, Volume: 10

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzamides; Calcium; Calcium Channel Blockers; Cats; Cerebral Cortex; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; Geniculate Bodies; In Vitro Techniques; Membrane Potentials; Models, Neurological; Neurons; Nonlinear Dynamics; Organophosphorus Compounds; Patch-Clamp Techniques; Piperidines; Pyridazines

2016